van Es-Johansson An — SEC insider filings

SEC reporting owner CIK 1795902. 20 insider filings on record with FilingPulse; latest filed 2026-10-01.

Transaction summary — filings shown

Covers all 20 filings on record, filed 2020-12-17 to 2026-10-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CERENOME, INC. (CNSY)Director9——12
LUMOS PHARMA, INC. (LUMO)Director5——11
Savara Inc (SVRA)Director6——6

Insider filings — van Es-Johansson An

FiledFormIssuerReported transactionsSource
2026-10-014CERENOME, INC. (CNSY)Option exercise (M): 921 @ $0 · Option exercise (M): 921 (derivative) @ $0EDGAR
2026-07-014PLUS THERAPEUTICS, INC. (PSTV)Option exercise (M): 922 @ $0 · Option exercise (M): 922 (derivative) @ $0EDGAR
2026-05-184PLUS THERAPEUTICS, INC. (PSTV)Grant/award (A): 3,686 (derivative) @ $0 · Grant/award (A): 3,686 (derivative) @ $0EDGAR
2025-12-114Savara Inc (SVRA)Grant/award (A): 40,000 @ $0EDGAR
2025-08-154PLUS THERAPEUTICS, INC. (PSTV)Grant/award (A): 297,794 (derivative) @ $0EDGAR
2025-02-204PLUS THERAPEUTICS, INC. (PSTV)Grant/award (A): 40,122 (derivative) @ $0EDGAR
2024-12-164Savara Inc (SVRA)Grant/award (A): 40,000 @ $0EDGAR
2024-12-134LUMOS PHARMA, INC. (LUMO)Disposition to issuer (D): 1,100 · Disposition to issuer (D): 3,345 (derivative) · Disposition to issuer (D): 3,328 (derivative) · Disposition to issuer (D): 3,431 (derivative) · Disposition to issuer (D): 2,910 (derivative) · Disposition to issuer (D): 5,729 (derivative)EDGAR
2024-09-124PLUS THERAPEUTICS, INC. (PSTV)Grant/award (A): 3,650 (derivative) @ $0EDGAR
2024-06-074LUMOS PHARMA, INC. (LUMO)Grant/award (A): 3,328 (derivative) @ $0EDGAR
2024-02-264PLUS THERAPEUTICS, INC. (PSTV)Grant/award (A): 2,250 (derivative) @ $0EDGAR
2023-12-154Savara Inc (SVRA)Grant/award (A): 22,500 @ $0EDGAR
2023-05-124LUMOS PHARMA, INC. (LUMO)Grant/award (A): 3,345 (derivative) @ $0EDGAR
2023-02-174PLUS THERAPEUTICS, INC. (PSTV)Grant/award (A): 20,182 (derivative) @ $0EDGAR
2022-12-154Savara Inc (SVRA)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2022-05-094LUMOS PHARMA, INC. (LUMO)Grant/award (A): 3,431 (derivative) @ $0EDGAR
2021-12-144Savara Inc (SVRA)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2021-05-274PLUS THERAPEUTICS, INC. (PSTV)Grant/award (A): 6,336 (derivative) @ $0EDGAR
2021-05-244LUMOS PHARMA, INC. (LUMO)Grant/award (A): 367 @ $0 · Grant/award (A): 2,910 (derivative) @ $0EDGAR
2020-12-174Savara Inc (SVRA)Grant/award (A): 40,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-17 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1795902 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs